ArticleFrontiers in pharmacology2024

A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis.

Sunyoung Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.